Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy
Clinical trial NCT03302247 · TERMINATED
Trial details
- NCT number
- NCT03302247
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2019-03-21
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.